Found: 63
Select item for more details and to access through your institution.
Safety and Efficacy of Low-Dose Bexarotene and PUVA in the Treatment of Patients with Mycosis Fungoides.
- Published in:
- American Journal of Clinical Dermatology, 2008, v. 9, n. 3, p. 169, doi. 10.2165/00128071-200809030-00005
- By:
- Publication type:
- Article
Evaluation of automated capillary complete blood counts for routine clinical decision making in a large cohort of hematological patients, using Mindray BC‐3000 Plus Auto and Sysmex XE‐5000 hematology analyzers.
- Published in:
- International Journal of Laboratory Hematology, 2020, v. 42, n. 5, p. 565, doi. 10.1111/ijlh.13237
- By:
- Publication type:
- Article
Pembrolizumab-induced Remission After Failure of Axicabtagene Ciloleucel: Case Report and Literature Review.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Paraneoplastic Intrahepatic Cholestasis in Supradiaphragmatic Classical Hodgkin Lymphoma Successfully Treated With Brentuximab Vedotin: A Case Report and Review of the Literature.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Nodular Lymphocyte-Predominant Hodgkin Lymphoma in a Patient with Familial Mediterranean Fever.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2022, v. 14, n. 1, p. 1, doi. 10.4084/MJHID.2022.059
- By:
- Publication type:
- Article
Detection of CALR Mutations Using High Resolution Melting Curve Analysis (HRMA); Application on a Large Cohort of Greek ET and MF Patients.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2019, v. 11, n. 1, p. 1, doi. 10.4084/MJHID.2019.009
- By:
- Publication type:
- Article
Toward a paradigm shift in prognostication and treatment of early‐stage Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 3, p. 823, doi. 10.1111/bjh.19657
- By:
- Publication type:
- Article
Expression of the novel tumour suppressor sterile alpha motif and HD domain‐containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. 488, doi. 10.1111/bjh.17352
- By:
- Publication type:
- Article
Validation of the simplified International Prognostic Score3 in a Hellenic cohort of patients with advanced‐stage Hodgkin‐lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. e335, doi. 10.1111/bjh.16903
- By:
- Publication type:
- Article
Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pancytopenia, eosinophilia and coagulation disorders in a patient with T‐acute lymphoblastic leukemia in prolonged remission.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. 632, doi. 10.1002/ajh.26145
- By:
- Publication type:
- Article
A Novel Immunological Assay for Hepcidin Quantification in Human Serum.
- Published in:
- PLoS ONE, 2009, v. 4, n. 2, p. 1, doi. 10.1371/journal.pone.0004581
- By:
- Publication type:
- Article
Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 8, p. 2279, doi. 10.1007/s00277-023-05214-5
- By:
- Publication type:
- Article
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 9, p. 2279, doi. 10.1007/s00277-021-04421-2
- By:
- Publication type:
- Article
Prognostic Impact of Serum β 2 -Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 238, doi. 10.3390/cancers16020238
- By:
- Publication type:
- Article
Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1917, doi. 10.3390/cancers14081917
- By:
- Publication type:
- Article
Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4480, doi. 10.3390/cancers13174480
- By:
- Publication type:
- Article
Immunotherapy in Hodgkin Lymphoma: Present Status and Future Strategies.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1071, doi. 10.3390/cancers11081071
- By:
- Publication type:
- Article
Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720902911
- By:
- Publication type:
- Article
Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720966121
- By:
- Publication type:
- Article
CD138 expression helps distinguishing Waldenström's macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
CD138 Expression Helps Distinguishing Waldenström's Macroglobulinemia (WM) From Splenic Marginal Zone Lymphoma (SMZL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 99, doi. 10.3816/CLML.2011.n.019
- By:
- Publication type:
- Article
Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia.
- Published in:
- Advances in Hematology, 2013, p. 1, doi. 10.1155/2013/359071
- By:
- Publication type:
- Article
Study of bone metabolism and angiogenesis in patients undergoing high‐dose chemotherapy/autologous hematopoietic stem cell transplantation.
- Published in:
- European Journal of Haematology, 2018, v. 100, n. 2, p. 131, doi. 10.1111/ejh.12990
- By:
- Publication type:
- Article
Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 5, p. 409, doi. 10.1111/ejh.12923
- By:
- Publication type:
- Article
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
- Published in:
- European Journal of Haematology, 2006, v. 77, n. 5, p. 387, doi. 10.1111/j.1600-0609.2006.00725.x
- By:
- Publication type:
- Article
Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab.
- Published in:
- European Journal of Haematology, 2006, v. 77, n. 4, p. 300, doi. 10.1111/j.1600-0609.2006.00720.x
- By:
- Publication type:
- Article
Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
- Published in:
- European Journal of Haematology, 2004, v. 72, n. 4, p. 252, doi. 10.1046/j.0902-4441.2003.00205.x
- By:
- Publication type:
- Article
Case Report Ida-FLAG plus imatinib mesylate-induced molecular remission in a patient with chemoresistant Ph<sup>1</sup>(+) acute myeloid leukemia.
- Published in:
- 2004
- By:
- Publication type:
- Book Review
Hodgkin's lymphoma in first relapse following chemotherapy or combined modality therapy: analysis of outcome and prognostic factors after conventional salvage therapy.
- Published in:
- European Journal of Haematology, 2002, v. 68, n. 5, p. 289, doi. 10.1034/j.1600-0609.2002.01721.x
- By:
- Publication type:
- Article
The splenic form of mantle cell lymphoma.
- Published in:
- European Journal of Haematology, 2002, v. 68, n. 1, p. 12, doi. 10.1034/j.1600-0609.2002.00551.x
- By:
- Publication type:
- Article
Progressive Multifocal Leukoencephalopathy Following Treatment With Obinutuzumab in a Patient With Non-Hodgkin Follicular Lymphoma: A Case Report.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 7, p. e601, doi. 10.1016/j.clml.2021.02.016
- By:
- Publication type:
- Article
Treatment intensification might not improve survival in high‐grade B‐cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 776, doi. 10.1002/hon.3130
- By:
- Publication type:
- Article
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 97, doi. 10.1002/hon.3096
- By:
- Publication type:
- Article
Successful salvage of primary progressive Hodgkin lymphoma with the combination of post‐transplant brentuximab vedotin and radiotherapy: Combining novelty and tradition.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 258, doi. 10.1002/hon.2801
- By:
- Publication type:
- Article
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher‐risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 541, doi. 10.1002/hon.2756
- By:
- Publication type:
- Article
Central nervous system involvement in primary bone marrow or splenic marginal zone lymphoma: Report of two cases and review of the literature.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Detection of L265P MYD-88 mutation in a series of clonal B-cell lymphocytosis of marginal zone origin (CBL-MZ).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents.
- Published in:
- Hematological Oncology, 2013, v. 31, n. 2, p. 356, doi. 10.1002/hon.2026
- By:
- Publication type:
- Article
B-chronic lymphocytic leukemia: practical aspects.
- Published in:
- Hematological Oncology, 2002, v. 20, n. 3, p. 103, doi. 10.1002/hon.696
- By:
- Publication type:
- Article
The prognostic value of monosomal karyotype (MK) in higher‐risk patients with myelodysplastic syndromes treated with 5‐Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. 895, doi. 10.1002/ajh.25111
- By:
- Publication type:
- Article
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
- Published in:
- British Journal of Haematology, 2007, v. 137, n. 3, p. 240, doi. 10.1111/j.1365-2141.2007.06561.x
- By:
- Publication type:
- Article
Identification of Very Low‐Risk Subgroups of Patients with Primary Mediastinal Large B‐Cell Lymphoma Treated with R‐CHOP.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 597, doi. 10.1002/onco.13789
- By:
- Publication type:
- Article
Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens.
- Published in:
- Oncologist, 2016, v. 21, n. 3, p. 343, doi. 10.1634/theoncologist.2015-0251
- By:
- Publication type:
- Article
Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy.
- Published in:
- Oncologist, 2013, v. 18, n. 2, p. 190, doi. 10.1634/theoncologist.2012-0251
- By:
- Publication type:
- Article
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone with or Without Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma: The Emerging Standard of Care.
- Published in:
- Oncologist, 2012, v. 17, n. 2, p. 239, doi. 10.1634/theoncologist.2011-0275
- By:
- Publication type:
- Article
Early-Stage Gastric MALT Lymphoma: Is It a Truly Localized Disease?
- Published in:
- Oncologist, 2009, v. 14, n. 2, p. 148, doi. 10.1634/theoncologist.2008-0178
- By:
- Publication type:
- Article
A Case Report of Chronic Myelogenous Leukemia Presenting as Blastic Crisis with a T-Cell Acute Lymphoblastic Leukemia Phenotype: Awareness of a Rare Entity.
- Published in:
- Acta Haematologica, 2023, v. 146, n. 6, p. 530, doi. 10.1159/000529911
- By:
- Publication type:
- Article